Poland· PL-100532515

VacPertagen

A pertussis, gereinigtes antigen (azellulär) product containing pertussis vaccine (recombinant, acellular, component, adsorbed), registered in Poland by BioNet Europe. The same ATC class is registered in 8 of our 19 countries.

ATC J07AJ02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVacPertagenATCJ07AJ02REGISTER NO.PL-100532515PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Pertussis, gereinigtes antigen (azellulär) is registered in 8 of 19 countries.

Countries holding a registration under ATC J07AJ02 (pertussis, gereinigtes antigen (azellulär)), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Pertussis, gereinigtes antigen (azellulär) · ATC J07AJ02

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pertussis vaccine (recombinant, acellular, component, adsorbed)
Manufacturer
BioNet Europe
Country
Poland (PL)
ATC code
J07AJ02
ATC class
Pertussis, gereinigtes Antigen (azellulär)
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pertussis, gereinigtes antigen (azellulär) in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pertussis, gereinigtes antigen (azellulär) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2683bfe2-5d78-4f0c-89f8-feb1ce85a9bb
GET /v1/drugs/2683bfe2-5d78-4f0c-89f8-feb1ce85a9bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina do wstrzykiwań w ampułko-strzykawce",
  "source": "urpl",
  "strength": "0,5 ml",
  "packaging": "Rp ¦ EU/1/25/1999/001 ¦ 165682\n1 amp.-strzyk. 0,5 ml",
  "substance": "Szczepionka przeciw krztuścowi (rekombinowana, bezkomórkowa, złożona, adsorbowana) 0.5 ml",
  "common_name": "Pertussis vaccine (recombinant, acellular, component, adsorbed)",
  "pl_product_id": "100532515",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about pertussis, gereinigtes antigen (azellulär).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.